Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway

Cancer Research

Volumn 61, Issue 14, 2001, Pages 5652-5659

  Yang, Jun ^a   Fizazi, Karim ^a   Peleg, Sara ^a   Sikes, Charles R ^a   Raymond, A Kevin ^b   Jamal, Nausheen ^a   Hu, Min ^a   Olive, Matilde ^a   Martinez, Luis A ^a   Wood, Christopher G ^a   Logothetis, Christopher J ^a   Karsenty, Gerard ^c   Navone, Nora M ^a  

^a Department of Genitourinary Medical Oncology ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYOGLOBIN; MYOSIN LIGHT CHAIN; OSTEOPONTIN; PROCOLLAGEN; PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE METASTASIS; CANCER CELL; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; MYOBLAST; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANIMALS; BLOTTING, NORTHERN; BONE AND BONES; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, SCID; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OSTEOBLASTS; OSTEOCALCIN; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RNA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0035878944     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Cancer statistics
2. Early detection of prostate cancer
3. Management of cancer of the prostate
4. Events in the natural history of prostate cancer: Using salvage curves, mean age distributions and contingency coefficients
5. The distribution of secondary growth in cancer of the breast
6. Seed and soil' revised: Mechanisms of site-specific metastasis
7. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment
8. Model systems of prostate cancer: Uses and limitations
9. Preclinical models of prostate cancer
10. Establishment of two human prostate cancer cell lines derived from a single bone metastasis
11. TabBO: A model reflecting common molecular features of androgen-independent prostate cancer
12. Immortilazed murine osteoblast derived from BMP 2-T-antigen expressing transgenic mice
13. 1, 25-Dihydroxyvitamin D3 inhibits osteocalcin expression in mouse through an indirect mechanism
14. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene
15. Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells
16. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
17. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO
18. The genetic transformation of bone biology
19. Expression of an osteoblast-specific transcription factor following co-culture with prostate cancer bone metastases
20. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations
21. Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro
22. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro
23. Species-divergent regulation of human and mouse osteocalcin genes by calciotropic hormones
24. Signaling by fibroblast growth factor (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induced apoptosis in osteoblasts
25. Prostate-derived soluble factors block osteoblast differentiation in culture
26. Inhibition of osteoblast cell differentiation by conditioned medium derived from the human prostatic cancer cell line PC-3 in vitro
27. Genetics of skeletogenesis
28. CBFA1: A molecular switch in osteoblast biology
29. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone
30. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential
31. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro
32. Bone morphogenetic protein-2 converts the differentiation pathway of C2Cl2 myoblasts into the osteoblast lineage
33. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2Cl2 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation
34. Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways
35. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1
36. Prostatic tumor (R3327) skeletal metastasis
37. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines
38. Significance of increased phosphatase activity of bone at the site of osteoplastic metastases secondary to carcinoma of the prostate gland
39. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGFβ and a proteolytic modulation of cell adhesion receptors
40. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTH-rP stimulated cAMP accumulation in mouse osteoblasts
41. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells
42. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo
43. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells
44. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia
45. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate
46. Human prostatic cancer cells, PC-3, elaborate mitogenic activity which selectively stimulates human bone cells
47. Asynchronous activation of 10 muscle-specific protein (MSP) genes during zebrafish somitogenesis
48. Role of E and CArG boxes in developmental regulation of muscle glycogen phosphorylase promoter during myogenesis
49. Life without myoglobin
50. Activation of the gene encoding the glycolytic enzyme beta-enolase during early myogenesis precedes an increased expression during fetal muscle development
51. Ryanodine receptor isoforms in excitation-contraction coupling